Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
Τόπος έκδοσης: | PLoS One 17(2022)10, S. e0274315 |
---|---|
Κύριοι συγγραφείς: | Hawchar, Fatime (Συγγραφέας), Tomescu, Dana (Συγγραφέας), Henzler, Dietrich (Συγγραφέας) |
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
2022
|
Θέματα: | |
Διαθέσιμο Online: | https://doi.org/10.1371/journal.pone.0274315 |
Σχετικά τεκμήρια: | In:
PLoS One |
Παρόμοια τεκμήρια
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
ανά: Köhler, Thomas, κ.ά.
Έκδοση: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
ανά: Köhler, Thomas, κ.ά.
Έκδοση: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
ανά: Köhler, Thomas, κ.ά.
Έκδοση: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
ανά: Schultz, Philipp, κ.ά.
Έκδοση: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
ανά: Al-Batran, Salah-Eddin, κ.ά.
Έκδοση: (2021)